Immunotherapy with Surgery Raises Hopes for Mesothelioma Patients
Researchers believe combining surgery with immunotherapy vaccines may advance mesothelioma treatment.
Disparities Discovered Among Blacks, Whites with Mesothelioma
Study finds treatment and survival disparities among blacks and whites diagnosed with mesothelioma.
Ochsner Launches Mesothelioma Patient Assistance Fund
Ochsner Cancer Institute launches the Mesothelioma Patient Assistance Fund — the first mesothelioma-specific cancer fund in the Southeast.
Bevacizumab May Be Next Standard of Care for Mesothelioma
Doctors at the 2015 American Society of Clinical Oncology annual meeting suggested adding bevacizumab to traditional chemotherapy regimen for mesothelioma.
Alarming Spike in Imported Asbestos Products in Canada
A significant jump in imported asbestos products in Canada raises health concerns and renews interest in a national asbestos ban.
Powerful Skin Cancer Drug Stops Mesothelioma Tumor Growth
Researchers at the University of Pennsylvania School of Medicine discover pembrolizumab also can stop mesothelioma and lung cancer tumor growth.
Mesothelioma Patients Live Longer After Aggressive Cancer Surgery
Researchers find pleurectomy/decortication may impact breathing in some patients but ultimately leads to long-term survival when cancer is diagnosed early.
Upcoming Mesothelioma Symposium Will Focus on Latest Research
Dr. Robert Cameron and other mesothelioma specialists are set to discuss latest treatment breakthroughs with health care professionals and the public.
New Clinical Trial Shows Promise for Life-Extending Mesothelioma Drug
Early results from a clinical trial that mirrors a multicenter study shows immunotherapy drug tremelimumab is extending patients’ lives.
FDA Approves New Use for Immunotherapy Drug in Mesothelioma Treatment
Ongoing clinical trials show immunotherapy vaccine CRS-207 is shrinking tumors in mesothelioma patients and helping them regain their appetite.
New Mesothelioma Treatment Options Are Emerging for Patients
Renowned mesothelioma specialists say there are several emerging treatment options for mesothelioma in ongoing clinical trials across the country.
Indirect Exposure to Asbestos Is Still Risky for Sheet Metal Workers
New study shows sheet metal workers in the U.S. who are exposed to asbestos indirectly are still at risk of developing mesothelioma and other diseases.
New Lung Cancer Drug Opdivo May Hold Hope for Mesothelioma Patients
Some researchers say Opdivo may soon be used to treat other types of cancers, including mesothelioma.
UK Study Shows Promise for Epithelioid Mesothelioma Patients
A U.K. Study shows promise in the cancer treatment of patients with epithelioid mesothelioma.
Lymphoma Drug May Kill Some Mesothelioma Cells
Researchers at Case Western Reserve University find that Adcetris lymphoma drug may fight and kill some mesothelioma cell lines containing CD30 protein.